Journal
Clinical Cancer Research
Publication Date
1-5-2024
Volume
30
Issue
1
First Page
63
Last Page
73
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-22-3627
Rights and Permissions
Petrylak DP, Eigl BJ, George S, Heath EI, Hotte SJ, Chism DD, Nabell LM, Picus J, Cheng SY, Appleman LJ, Sonpavde GP, Morgans AK, Pourhosseini P, Wu R, Standley L, Croitoru R, Yu EY. Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma. Clin Cancer Res. 2024 Jan 5;30(1):63-73. doi: 10.1158/1078-0432.CCR-22-3627. ©2023 The Authors; Published by the American Association for Cancer Research This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
Recommended Citation
Petrylak, Daniel P; Picus, Joel; and et al., "Phase I dose-escalation study of the safety and pharmacokinetics of AGS15E monotherapy in patients with metastatic urothelial carcinoma." Clinical Cancer Research. 30, 1. 63 - 73. (2024).
https://digitalcommons.wustl.edu/oa_4/3083
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
